Cote d'Ivoire vs Iran: Cause of death, by non-communicable diseases, ages 15-59, male
Cote d'Ivoire
41.5%
in 2021
Iran
40.8%
in 2021
Cote d'Ivoire rank
127th
Iran rank
130th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Cote d'Ivoire
- Iran
How they compare
Cote d'Ivoire currently reports 41.5% against 40.8% in Iran, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iran ahead.
Cote d'Ivoire ranks 127th and Iran ranks 130th of 185 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.0% | 55.1% | 35.2% | Iran |
| 2010s | 37.5% | 59.1% | 21.7% | Iran |
| 2020s | 41.7% | 44.6% | 2.8% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Cote d'Ivoire or Iran?
- Cote d'Ivoire, at 41.5% against 40.8% in Iran as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Cote d'Ivoire and Iran?
- 0.7%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and Iran rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Cote d'Ivoire ranks 127th and Iran ranks 130th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.